Authors: Issa EHB, Alghazo EM, Gharaibeh R, Momani NB, Taha DZ, Jaradat RJ, Alzu’bi A, Almahasneh FA, Abu-El-Rub E, Al-Zoubi RM.
DOI: 10.1093/jnen/nlaf021
Abstract Summary
Mesenchymal stem cells (MSCs) show promising potential for treating neurodegenerative diseases like Parkinson’s, Alzheimer’s, stroke, and multiple sclerosisโconditions that currently lack effective therapies. Their unique ability to proliferate, differentiate, and self-renew makes them attractive therapeutic candidates, though more research is needed to fully understand how they work and optimize their clinical applications.
Why Brain? ๐ง
MSCs show promise for treating Parkinson’s, stroke, MS, and Alzheimer’s, offering new hope where treatments are lacking, though mechanisms and in vivo applications need further study.
Study Limitations:
Study limitations were not specified in the abstract.
License: cc by.
The image is AI-generated for illustrative purposes only. Courtesy of Midjourney.
